2018 News

Peter Hamer joins SurgaColl as Chief Executive Officer

Alderley Park, UK – 10th December 2018. SurgaColl, a regenerative medicine company, today announced the appointment of Peter Hamer as Chief Executive Officer. Mr. Hamer succeeds Bill Allan as CEO following Bill’s decision to retire f...

Maxwellia expand their team with two new appointments

Maxwellia has expanded their team of switch experts with two new appointments following their relocation to the Alderley Park Accelerator.  Maxwellia, the UK’s only ‘prescription to over the counter (OTC)’ medicines c...

Oxford BioTherapeutics Expands Strategic Collaboration with WuXi Biologics

Shanghai China and Oxford UK, December 11, 2018 –WuXi Biologics (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing and Oxford B...

Med-Tech companies triumph at the Bionow Awards

The outstanding companies and leaders of the North’s life sciences sector – which is worth more than £13bn to the economy- were honoured last night at the 17th annual Bionow Awards.  More than 300 people attended the aw...

Blueberry Therapeutics Announce Positive Results from a Phase I-II Clinical Trial

Alderley Park, UK, 21stNovember 2018– Blueberry Therapeutics Limited (“Blueberry Therapeutics”), a modern drug discovery and development company committed to the development of innovative new therapies for the treatment of comm...

From our portfolio



CanCertain (formerly CLYZ Labs) is developing a testing service to select the best drug therapy f...

viewview our portfolio

Our Team

Rob Carroll

view complete team

Contact us

Binder House
7 Narborough Wood Park
Desford Road
LE19 4XT

Tel: 0116 238 8200